Bristol-Myers Squibb: Bristol-Myers Squibb Included in Dow Jones Sustainability Index
 
Bristol-Myers Squibb Included in Dow Jones Sustainability Index Recognition of the Company’s Comprehensive Sustainability Achievements

Decade of Hope
Our Devens facility in Massachusetts. This state-of-the-art biologics manufacturing facility represents our single largest capital investment and we see this as an opportunity to incorporate green practices in building design.
Bristol-Myers Squibb was recently recognized in the 2009 Dow Jones Sustainability North America Index of leading sustainability-driven companies. The Index selects companies based on a systematic corporate sustainability assessment that identifies the leading sustainability-driven companies in each industry sector. These insights are used to generate attractive long-term investment returns by the Dow Jones Sustainability Investment Group and are made available to other investors. A total of $9 billion is invested in its family of Sustainability Index funds, and the index is used by other funds.

“We are delighted to be included in this prestigious and important recognition,” says Susan Voigt, vice president, Environment, Health, Safety and Sustainability. “The Dow Jones Index has one of the most comprehensive criteria for corporate sustainability, and this is a real tribute to our company and its employees at every level of the organization.”

The Dow Jones Sustainability Indexes follow a best-in-class approach and includes sustainability leaders from each industry on a global and regional level. The annual review is based on a thorough analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, branding, climate change mitigation, supply chain standards and labor practices. Bristol-Myers Squibb was listed as among 139 companies that met the criteria for the North American Index.

“It’s a moving target, and every year the bar gets higher,” says Robert Draeger, director, EHS Strategies and Outreach, noting that the company had last been included on the Index in 2006. “What put us over the top? It was really a broad combination of many things, with contributions from across the entire company.”

In making its assessment, Dow Jones uses a comprehensive questionnaire that was distributed to 2,500 companies worldwide, including 600 North American firms. Laura Bradford, associate director, Strategies and Outreach, cites examples of the range of criteria that was used in the assessment: “They looked at what we’ve done with regard to access to medicines, employee development, philanthropy, bioethics and innovation, as well as green and sustainable building design, water usage, energy and waste reduction, and even the fact that we’ve included hybrid vehicles in our fleet.”

“This clearly recognizes the progress we have achieved with our Sustainability 2010 Goals,” says Draeger. “It’s also significant that we updated our sustainability website – making it more comprehensive as well as more accessible – so that anyone who wants to see what we’re doing with regard to sustainability can easily find out.”

To access the company’s sustainability website, go to www.bms.com/sustainability/

Other recent significant recognitions:

  • Bristol-Myers Squibb was listed as 8th among 500 of America’s largest corporations in Newsweek’s Green Ranking
  • The Corporate Responsibility Officer CRO Magazine recognized Bristol-Myers Squibb as the 2009 number one “Best Corporate Citizen”
  • For the 12th consecutive year, Bristol-Myers Squibb was included among Working Mother Magazine’s 100 Best Companies
  • Bristol-Myers Squibb was listed 40th among Barron’s 2009 Most Respected Companies

 
 
 
 


You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.
You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.